The Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses, a study has found. Two jabs of either vaccine give a similar level of protection against symptomatic disease from the Indian variant as they do for the Kent one. However, both vaccines were only 33% effective against the Indian variant three weeks after the first dose.